In AD pathophysiology, GSK-3β plays a pivotal role, impacting various disease aspects, including tau phosphorylation, Aβ production, memory, neurogenesis, synaptic function, and serving as a potential therapeutic target for AD. Here, GSK3B is linked to Alzheimer disease.